Kamrava, Mitchell

Evaluation of Mobile Health Applications to Track Patient-Reported Outcomes for Oncology Patients: A Systematic Review

Lu, D. J., Girgis, M., David, J. M., Chung, E. M., Atkins, K. M., & Kamrava, M. (2021) · Advances in Radiation Oncology

Mobile Health and mHealth ApplicationsCancer survivorship and care

Cited by 72

Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer

Walsh, C. S., Kamrava, M., Rogatko, A., Kim, S., Li, A., Cass, I., Karlan, B., & Rimel, B. J. (2021) · PLOS ONE

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 27

A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver

Gulley, J. L., Madan, R. A., Tsang, K.-Y., Arlen, P. M., Camphausen, K., Mohebtash, M., Kamrava, M., Schlom, J., & Citrin, D. (2011) · Expert Opinion on Biological Therapy

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 26